✦ LIBER ✦

Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin-releasing peptide levels

✍ Scribed by Koichi Goto; Tetsuro Kodama; Fumihiko Hojo; Kaoru Kubota; Ryutaro Kakinuma; Taketoshi Matsumoto; Hironobu Ohmatsu; Ikuo Sekine; Kanji Nagai; Yutaka Nishiwaki

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 300 KB
Volume: 82
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19980315)82:6<1056::aid-cncr7>3.0.co;2-c

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Progastrin-releasing peptide (proGRP) is a specific

📜 SIMILAR VOLUMES

Elevated levels of serum aldolase A in p

Elevated levels of serum aldolase A in patients with renal cell carcinoma

✍ Takashi, M. ;Zhu, Y. ;Nakano, Y. ;Miyake, K. ;Kato, K. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 371 KB

To clarify whether serum aldolase A is a useful biomarker for renal cell carcinoma (RCC), we determined serum levels of the aldolase A isozyme by an enzyme immunoassay in patients suffering from RCC, other urological tumors, and benign urological diseases. Forty-six of 126 patients with RCC (37%) ha

Postoperative serum carcinoembryonic ant

Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma : Subnormal levels as an indicator of favorable prognosis

✍ Noriyoshi Sawabata; Hajime Maeda; Soichiro Yokota; Shin-ichi Takeda; Masaru Koma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Abstract ## BACKGROUND Elevated serum carcinoembryonic antigen (CEA) levels are sometimes attributable to the production of CEA by malignant cells, and in turn, the antigen itself can enhance the metastatic potential of malignant cells. The authors speculated that low serum CEA levels might be

Study of pretreatment serum levels of HE

Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

✍ Andrea Ardizzoni; Mara A. Cafferata; Michela Paganuzzi; Rosangela Filiberti; Pao 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Serum vascular endothelial growth factor

Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma : A possible diagnostic tool for lymph node metastasis

✍ Masaya Tamura; Yasuhiko Ohta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND The authors measured circulating vascular endothelial growth factor‐C (VEGF‐C) and vascular endothelial growth factor (VEGF) levels in patients with primary nonsmall cell lung carcinoma and assessed its usefulness as a diagnostic tool for determining lymph node metastasis

Elevated pretreatment serum concentratio

Elevated pretreatment serum concentration of YKL-40—An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer

✍ Ina Thöm; Birte Andritzky; Gunter Schuch; Iris Burkholder; Lutz Edler; Julia S. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

Pro-gastrin–releasing peptide as a facto

Pro-gastrin–releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation

✍ Kan Yonemori; Minako Sumi; Naoko Fujimoto; Yoshinori Ito; Atsushi Imai; Yoshikaz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB